Search

Back to search result

Juno Therapeutics Headquarters

  • JUNO Therapeutics wanted a new, world-class headquarters and R&D center to provide flexibility for the future and create an environment of communication and collaboration. Through end-user interviews, mock-ups and brainstorming sessions, we worked as a team to realize these goals.
  • Juno Therapeutics Headquarters
  • Juno Therapeutics Headquarters
  • Juno Therapeutics Headquarters
  • Juno Therapeutics Headquarters
  • Juno Therapeutics Headquarters

JUNO Therapeutics is a biotech organization with a vision of growing an independent operation to revolutionize the field of immunotherapy and medical treatment. To support the company's operational strategy and to establish a world-class headquarters and research facility, JUNO executed a lease for approximately 142,000-SF of space within the new 400 Dexter Project. The Juno Headquarters Project will provide a long-term headquarters building that fits JUNO's current needs and has the flexibility to accommodate future growth. The project incorporates laboratory space, office and conference uses. Floors will promote open communication and collaboration and continue to inspire the development of breakthrough science while promoting employee recruitment and retention. 

Contacts

Beth Miller
Vice President, Communications
Skanska USA Inc.

Facts

Service: Construction, Commercial development
Mark segment: Offices
Start date: 2016
Completion date: 2017
Clients: Juno Therapeutics
Country: United States
City: Seattle
Project status: Completed